The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genetic Vaccine Market Research Report 2025
Synopsis
Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.
The global Genetic Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genetic Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Vaccine.
Report Scope
The Genetic Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Medicago
Pukang Biologic Technology
Johnson & Johnson
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
Novavax
CureVac
Arcturus Therapeutics
BioNTech
Takeda
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genetic Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genetic Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.
The global Genetic Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genetic Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Vaccine.
Report Scope
The Genetic Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Medicago
Pukang Biologic Technology
Johnson & Johnson
Clover Biopharmaceuticals
Suzhou Yuzhibo Biotechnology
Novavax
CureVac
Arcturus Therapeutics
BioNTech
Takeda
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genetic Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genetic Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Genetic Vaccine Market Overview
1.1 Product Overview and Scope of Genetic Vaccine
1.2 Genetic Vaccine Segment by Type
1.2.1 Global Genetic Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Genetic Vaccine Segment by Application
1.3.1 Global Genetic Vaccine Market Value by Application: (2024-2030)
1.3.2 Human
1.3.3 Animal
1.4 Global Genetic Vaccine Market Size Estimates and Forecasts
1.4.1 Global Genetic Vaccine Revenue 2019-2030
1.4.2 Global Genetic Vaccine Sales 2019-2030
1.4.3 Global Genetic Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genetic Vaccine Market Competition by Manufacturers
2.1 Global Genetic Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Genetic Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Genetic Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Genetic Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetic Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetic Vaccine, Product Type & Application
2.7 Genetic Vaccine Market Competitive Situation and Trends
2.7.1 Genetic Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetic Vaccine Players Market Share by Revenue
2.7.3 Global Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetic Vaccine Retrospective Market Scenario by Region
3.1 Global Genetic Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genetic Vaccine Global Genetic Vaccine Sales by Region: 2019-2030
3.2.1 Global Genetic Vaccine Sales by Region: 2019-2024
3.2.2 Global Genetic Vaccine Sales by Region: 2025-2030
3.3 Global Genetic Vaccine Global Genetic Vaccine Revenue by Region: 2019-2030
3.3.1 Global Genetic Vaccine Revenue by Region: 2019-2024
3.3.2 Global Genetic Vaccine Revenue by Region: 2025-2030
3.4 North America Genetic Vaccine Market Facts & Figures by Country
3.4.1 North America Genetic Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genetic Vaccine Sales by Country (2019-2030)
3.4.3 North America Genetic Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genetic Vaccine Market Facts & Figures by Country
3.5.1 Europe Genetic Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genetic Vaccine Sales by Country (2019-2030)
3.5.3 Europe Genetic Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetic Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Genetic Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genetic Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Genetic Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genetic Vaccine Market Facts & Figures by Country
3.7.1 Latin America Genetic Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genetic Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Genetic Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetic Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetic Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genetic Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genetic Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Genetic Vaccine Sales by Type (2019-2030)
4.1.1 Global Genetic Vaccine Sales by Type (2019-2024)
4.1.2 Global Genetic Vaccine Sales by Type (2025-2030)
4.1.3 Global Genetic Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Genetic Vaccine Revenue by Type (2019-2030)
4.2.1 Global Genetic Vaccine Revenue by Type (2019-2024)
4.2.2 Global Genetic Vaccine Revenue by Type (2025-2030)
4.2.3 Global Genetic Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Genetic Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genetic Vaccine Sales by Application (2019-2030)
5.1.1 Global Genetic Vaccine Sales by Application (2019-2024)
5.1.2 Global Genetic Vaccine Sales by Application (2025-2030)
5.1.3 Global Genetic Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Genetic Vaccine Revenue by Application (2019-2030)
5.2.1 Global Genetic Vaccine Revenue by Application (2019-2024)
5.2.2 Global Genetic Vaccine Revenue by Application (2025-2030)
5.2.3 Global Genetic Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Genetic Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Genetic Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Genetic Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Genetic Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoties Genetic Vaccine Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Genetic Vaccine Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer-Ingelheim Genetic Vaccine Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indian Immunologicals Genetic Vaccine Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Plumbline Life Sciences Genetic Vaccine Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
6.9 Medicago
6.9.1 Medicago Corporation Information
6.9.2 Medicago Description and Business Overview
6.9.3 Medicago Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medicago Genetic Vaccine Product Portfolio
6.9.5 Medicago Recent Developments/Updates
6.10 Pukang Biologic Technology
6.10.1 Pukang Biologic Technology Corporation Information
6.10.2 Pukang Biologic Technology Description and Business Overview
6.10.3 Pukang Biologic Technology Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pukang Biologic Technology Genetic Vaccine Product Portfolio
6.10.5 Pukang Biologic Technology Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Genetic Vaccine Description and Business Overview
6.11.3 Johnson & Johnson Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson & Johnson Genetic Vaccine Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Clover Biopharmaceuticals
6.12.1 Clover Biopharmaceuticals Corporation Information
6.12.2 Clover Biopharmaceuticals Genetic Vaccine Description and Business Overview
6.12.3 Clover Biopharmaceuticals Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Clover Biopharmaceuticals Genetic Vaccine Product Portfolio
6.12.5 Clover Biopharmaceuticals Recent Developments/Updates
6.13 Suzhou Yuzhibo Biotechnology
6.13.1 Suzhou Yuzhibo Biotechnology Corporation Information
6.13.2 Suzhou Yuzhibo Biotechnology Genetic Vaccine Description and Business Overview
6.13.3 Suzhou Yuzhibo Biotechnology Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Suzhou Yuzhibo Biotechnology Genetic Vaccine Product Portfolio
6.13.5 Suzhou Yuzhibo Biotechnology Recent Developments/Updates
6.14 Novavax
6.14.1 Novavax Corporation Information
6.14.2 Novavax Genetic Vaccine Description and Business Overview
6.14.3 Novavax Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Novavax Genetic Vaccine Product Portfolio
6.14.5 Novavax Recent Developments/Updates
6.15 CureVac
6.15.1 CureVac Corporation Information
6.15.2 CureVac Genetic Vaccine Description and Business Overview
6.15.3 CureVac Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CureVac Genetic Vaccine Product Portfolio
6.15.5 CureVac Recent Developments/Updates
6.16 Arcturus Therapeutics
6.16.1 Arcturus Therapeutics Corporation Information
6.16.2 Arcturus Therapeutics Genetic Vaccine Description and Business Overview
6.16.3 Arcturus Therapeutics Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Arcturus Therapeutics Genetic Vaccine Product Portfolio
6.16.5 Arcturus Therapeutics Recent Developments/Updates
6.17 BioNTech
6.17.1 BioNTech Corporation Information
6.17.2 BioNTech Genetic Vaccine Description and Business Overview
6.17.3 BioNTech Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 BioNTech Genetic Vaccine Product Portfolio
6.17.5 BioNTech Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Corporation Information
6.18.2 Takeda Genetic Vaccine Description and Business Overview
6.18.3 Takeda Genetic Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Takeda Genetic Vaccine Product Portfolio
6.18.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetic Vaccine Industry Chain Analysis
7.2 Genetic Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetic Vaccine Production Mode & Process
7.4 Genetic Vaccine Sales and Marketing
7.4.1 Genetic Vaccine Sales Channels
7.4.2 Genetic Vaccine Distributors
7.5 Genetic Vaccine Customers
8 Genetic Vaccine Market Dynamics
8.1 Genetic Vaccine Industry Trends
8.2 Genetic Vaccine Market Drivers
8.3 Genetic Vaccine Market Challenges
8.4 Genetic Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
